General Information of Drug (ID: DMZ0E69)

Drug Name
AAV-sFLT gene therapy
Indication
Disease Entry ICD 11 Status REF
Age-related macular degeneration 9B75.0 Phase 1 [1]
Cross-matching ID
TTD ID
D0J4CV

References

1 ClinicalTrials.gov (NCT00229736) A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease. U.S. National Institutes of Health.